Imagine the quiet anxiety in a home in rural Punjab when a government health worker knocks on the door with news of a free vaccine that could protect a daughter from cancer. Instead of relief, the mother hesitates. She has heard whispers: the vaccine might make her girl infertile, or it is unsafe, or perhaps it is simply unnecessary because her daughter is healthy. Across the border in Himachal Pradesh, the same scene unfolds differently—there, parents welcome the health worker, ask informed questions, and allow their daughters to be vaccinated. That difference in response is not minor. It is the difference between a coverage rate of over 90 percent and one of just 21 percent. Punjab’s Human Papillomavirus (HPV) vaccination campaign has stumbled, and the numbers reveal something far deeper than a logistical failure. They reveal a crisis of trust, information, and fear. Cervical cancer kills thousands of women in India every year, and the HPV vaccine is one of the most powerful weapons we have to prevent it. But a vaccine that no one is willing to accept is just a vial in a cold chain, and in Punjab, that vial is reaching only a fraction of the girls who need it most.
To understand why this matters so deeply, one must understand the disease itself. Cervical cancer develops in the cervix, the lower part of the uterus, and nearly all cases are caused by persistent infection with high-risk strains of HPV. This virus is extraordinarily common—it spreads through intimate skin-to-skin contact, and both males and females can carry it. In most people, the immune system clears the infection without any trouble, leaving no trace. But in some women, the virus lingers for years, slowly causing abnormal changes in the cells of the cervix. Over time, those changes can turn into cancer. The process is slow, almost sneaky. A girl may acquire HPV infection in her late teens or early twenties, but cervical cancer usually does not appear until much later, typically between the ages of 35 and 55. That long gap creates an illusion of safety. A young girl looks perfectly healthy, and so her parents think there is no threat. But the biological clock of cancer is already ticking, and the only way to stop it is to act decades before the disease would ever show its face. As Ludhiana Civil Surgeon Dr. Ramandeep Kaur explains, cervical cancer is the second most common cancer among women in India after breast cancer, and India alone accounts for nearly one-fourth of all cervical cancer deaths worldwide. These are not abstract statistics. They are mothers, daughters, sisters, and wives—women who die from a cancer that is almost entirely preventable.
The national campaign launched in February 2026 was supposed to change this story. It aimed to vaccinate 14-year-old girls with a free, single dose of the HPV vaccine, offering protection against the strains of the virus responsible for most cervical cancer cases. The timing is critical: the vaccine works best when given before a girl becomes sexually active, before she is ever exposed to HPV. If administered at the right age, the vaccine provides remarkably high protection, and it is not a new or experimental intervention. More than 160 countries have already incorporated HPV vaccination into their routine immunisation schedules, and millions of doses have been given around the world. In India, the vaccine is available free at government health facilities, while the private market charges anywhere from Rs 4,000 to Rs 6,000 per dose. So the problem in Punjab is not availability. The vaccine is there. The health workers are there. The campaign is there. What is missing is the trust of the community. A free vaccine is only valuable if people believe in it, and in Punjab, too many parents do not. That is the uncomfortable truth that no vaccination target or cold chain improvement can fix on its own.
A large part of the problem lies in the stubborn myths that continue to surround the HPV vaccine. The first and most damaging myth is that the vaccine is unsafe. This is simply not true. Scientific evidence from across the world has repeatedly demonstrated the safety of the HPV vaccine. The side effects that do occur are usually mild—pain at the injection site, redness, swelling, or a low-grade fever—similar to what people experience after many routine vaccines. But fear is a powerful thing. It spreads faster than fact, especially on social media and in neighbourhood conversations. Another common myth is that vaccination is unnecessary because girls are too young and too healthy to need it. This misunderstanding turns the vaccine’s greatest strength into its biggest obstacle. The vaccine is not meant for girls who are already sick. It is meant for girls who have not yet been exposed to the virus, and that is precisely why adolescence is the perfect time. Waiting until a girl is older, or until she shows signs of illness, would defeat the entire purpose. The vaccine is prevention at its purest—an intervention that works precisely because it happens before there is any visible problem. Perhaps the most cruel myth of all is the claim that HPV vaccination affects fertility or future reproductive health. There is no scientific evidence anywhere to support this idea. In fact, the opposite is true. By preventing cervical cancer, the vaccine protects a woman’s reproductive health. Cervical cancer and its treatments—surgery, radiation, chemotherapy—can devastate a woman’s ability to bear children or even end her life. The vaccine is not a threat to future motherhood; it is a shield for it. Yet these myths persist, whispered from one anxious parent to another, and each whisper leaves another girl unprotected.
Underneath the myths lies a deeper barrier: a profound lack of awareness and health literacy. Studies conducted in India have found that public knowledge about HPV vaccination, including its benefits and the recommended age, remains remarkably low. Many parents have never even heard of HPV. They do not know that cervical cancer is preventable. They do not understand why a vaccine meant to prevent a sexually transmitted infection is being offered to their innocent young daughters. That last concern is especially sensitive. In a society where conversations about sexuality are often uncomfortable and taboo, the very nature of HPV vaccination raises questions that many parents do not know how to ask. Fear of side effects, social resistance, suspicions about government health programmes—all of these mix together to create a powerful wall of hesitation. The result is that in Punjab, only one in five eligible girls has received the vaccine, a figure that stands in painful contrast to Himachal Pradesh’s overwhelming success. The difference is not in the vaccine or the health system. It is in the conversation around the vaccine. It is in the ability of health workers to reach parents with clear, honest, respectful information. It is in the willingness of communities to trust that message, and that trust is not built in a single visit or a single pamphlet. It is built over time, through repeated contact, through familiar faces, through stories from other mothers, and through the simple reassurance that comes when a respected doctor or village elder says, “I got my daughter vaccinated too.”
Punjab’s 21 percent coverage is not merely a vaccination statistic; it is a mirrored reflection of a larger challenge in public health—one that cannot be solved by simply extending deadlines or increasing supplies. The state has already extended the campaign until December and intensified outreach efforts, but success will ultimately depend on busting myths and convincing parents that this vaccine has the power to save their daughters’ lives. This is not just a medical campaign; it is a communication campaign, a trust-building exercise, and a social movement all rolled into one. It requires going beyond the usual announcements and door-to-door visits. It requires engaging community leaders, teachers, religious figures, and grandmothers. It requires opening dialogues that allow parents to express their fears without being judged, and then answering those fears with patience and facts. It requires showing women who have survived cervical cancer, and women who have lost mothers to it, and explaining that a single injection given at age 14 could have changed those stories. The vaccine is not a foreign conspiracy; it is not a miracle drug; it is simply a safe, proven, life-saving tool—no different from the vaccines that have already eliminated smallpox and nearly eradicated polio. Every year, thousands of Indian women die from a disease that was preventable. Every one of those deaths is a tragedy, and every one of them leaves behind children, husbands, and parents who will never stop grieving. The promise of the HPV vaccine is that no mother should have to lose a daughter to cervical cancer, and no daughter should have to lose her mother. But that promise can only be fulfilled if parents say yes—not because they are pressured, but because they understand. The health workers are ready. The vaccine is waiting. The girls are in school, dreaming of futures filled with careers, weddings, and children of their own. The only question left is whether we as a society can move beyond fear and embrace knowledge, whether we can protect our daughters from a cancer that should never reach them, and whether Punjab can transform its 21 percent into a story of triumph. The time to act is now, and the first step is not to open another vial—it is to open a conversation.